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Summary" 4-Methylumbelliferyl-~-N-acetylglucosamine 6-sulphate was syn- 
thesized and shown to be a substrate for the lysosomal N-acetylglucosamine- 
6-sulphate sulphatase (GlcNAc-6S sulphatase). Fibroblasts and leukocytes from 
3 different Sanfilippo D patients howed < 1% of mean normal GlcNAc-6S 
sulphatase activity. The enzymatic liberation of the fluorochrome from 4-methyl- 
umbelliferyl-~-N-acetylglucosamine 6-sulphate requires the sequential 
action of the GlcNAc-6S sulphatase and ~-N-acetylglucosaminidase. A normal 
level of :~-N-acetylglucosaminidase activity was insufficient o complete the 
hydrolysis of the reaction intermediate 4-methylumbelliferyl-c~-N-acetylgluco- 
saminide formed by the GlcNAc-6S sulphatase. A second incubation in the 
presence of excess :~-N-acetylglucosaminidase is n eded to avoid underestim- 
ation of the GlcNAc-6S sulphatase activity. 
Sanfilippo disease (mucopolysaccharidosis type III, MPS III) comprises four different 
autosomal recessive subtypes (for review see Neufeld and Muenzer 1989) and is 
clinically characterized by severe central nervous ystem degeneration, but only mild 
somatic abnormalities. Owing to different defects in the degradation of heparan 
sulphate, the patients tore excessive amounts of this mucopolysaccharide n various 
tissues. 
MPS III type D (McKusick 252940) is caused by a deficiency of N-acetylglucosamine- 
6-sulphate sulphatase (GlcNAc-6S sulphatase (EC 3.1.6.14); Kresse et al 1980). So far 
9 patients have been reported (Gatti et al 1982; Matalon et al 1982; Coppa et al 
1983; Kaplan and Wolfe 1987; Siciliano et al 1991). GlcNAc-6S sulphatase is routinely 
assayed using radiolabelled oligosaccharides derived from heparan sulphate (Kresse 
et al 1980; Freeman and Hopwood 1992). 
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In this paper we describe a novel, simple fluorimetric assay for GlcNAc-6S 
sulphatase, using 4-methylumbelliferyl-c~-D-glucosaminide (MU-c~GlcNAc-6S) and 
show its usefulness in the diagosis of MPS IIID. 
MATERIALS AND METHODS 
4-Methylumbelliferyl-c~-D-N-acetylglucosamine 6-sulphate (MU-c~GlcNAc-6S) was 
synthesized from MU-eGlcNAc, which was prepared as described (Voznyi 1991). To 
a solution of 0.31g MU-c~GlcNAc in 10ml abs. pyridine, 0.46g trityl chloride was 
added and the mixture was kept at room temperature for 72h. The mixture was 
cooled to 0°C; benzoyl chloride (0.5 ml in 5 ml dry chloroform) was added and after 
20h at room temperature, chloroform was added to dilute. The reaction products 
were then washed with water and saturated NaHCO3, and concentrated. The residue 
was treated with trifluoroacetic acid (0.5ml 90% in 5ml chloroform) for lb. 
Evaporation of volatile components and purification by silica chromatography 
(Zsiska and Meyer 1991) yielded 3,4,-O-benzoylated MU-eGlcNAc (compound 2; 
0.4g, 83%); [~]D = + 124° (C = 0.7, chloroform). To a solution of compound 2 (0.12g 
in 1.2 ml DMF), 0.22 g freshly prepared Et3NSO 3 complex was added. After 24 h at 
room temperature, the mixture was concentrated and purified by silica chromatogra- 
phy (Zsiska and Meyer 1991). This yielded the Et3N salt of 6-sulphated compound 
2 (compound 3;0.11 g, 70%);[c~]D = +91 ° (c = 0.5, chloroform), m.p. 220-224°C. To 
a solution of compound 3 (77 mg in 0.7 ml THF), 0.4 ml 1 mol/L NaOH was added 
and after 48 h stirring the mixture was neutralized with acetic acid, concentrated, 
applied to a silica column, eluted with toluene-ethanol-triethylamine (6:4:0.3) and 
crystallized from ethylacetate-ethyl ether to yield the Et3N salt of MU-eGlcNAc-6S 
(M~ 559). 
Total leukocytes were isolated from heparinized blood as described previously (van 
Diggelen et al 1990) and frozen until used. Skin fibroblasts were cultured according 
to routine procedures in Ham's F10 medium supplemented with 10% fetal bovine 
serum and antibiotics. The cells were harvested with trypsin 7 days after the last 
subculture and stored at -70°C. Fibroblasts from patients with Sanfilippo types A, 
B, C, Sanfilippo type D (84RD287, 84RD288 and 91RD415) or multiple sulphatase 
deficiency (91 RD 153) were obtained from the European Human Cell Bank, Rotterdam, 
the Netherlands (W.J. Kleijer). Leukocytes from a proven Sanfilippo D patient were 
kindly provided by Drs J.E.M. Groener and B.J.H.M. Poorthuis (Leiden). 
For the standard N-acetylglucosamine-6-sulphate sulphatase (GlcNAc-6S sulpha- 
tase) assay, homogenates were prepared by sonication of cell material in 0.25% (w/v) 
Triton X-100 in water. Reaction mixtures consisted of 5#1 homogenate (20#g 
protein for fibroblasts or 30#g for leukocytes) and 5#1 10mmol/L MU- 
~GlcNAc-6S in 0.2 mol/L sodium acetate buffer, pH 5.6, containing 20 mmol/L lead 
acetate. MU-~GlcNAc-6S will become available from Moscerdam Substrates (for 
inquiries: O.P. van Diggelen, Rotterdam). The reaction mixtures were incubated for 
17h (fibroblasts) or 24h (leukocytes) at 37°C, after which 20#1 twice-concentrated 
Mcllvain's phosphate-citrate buffer, pH 4.7, and 10#1 (16/~g protein) of a 
partially purified lysosomal enzyme preparation from bovine testis (Verheijen et al 
1982) was added and a second incubation of 6 h at 37°C was carried out. For certain 
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experiments homogenates were dialysed for 17 h against 0.9% NaC1. Reactions were 
terminated by the addition of 200#1 0.5mol/L NazCO3/NaHCO3, pH 10.7, and 
the fluorescence of 4-methylumbelliferone (MU) was measured on a Fluoroskan 
(Titertek) fluorimeter. 
Protein was determined as described previously (van Diggelen et al 1990). 
RESULTS 
The potential of 4-methylumbelliferyl-~-I>N-acetylglucosamine 6-sulphate (MU- 
~GlcNAc-6S) as substrate for the GlcNAc-6S sulphatase was tested. GlcNAc-6S 
sulphatase activity was barely detectable in undialysed homogenates, and a very low 
but significant activity, which did not increase with increasing amounts of protein, 
could be detected in dialysed fibroblast homogenates (Figure 1). Addition of lead 
acetate to reaction mixtures containing undialysed homogenates resulted in much 
higher activities that increased almost linearly with the amount of protein (Figure 1, 
open symbols). Addition of lead acetate to dialysed homogenates resulted in activities 
similar to those obtained in undialysed homogenates (not shown). 
Liberation of MU from MU-GlcNAc-6S by GlcNAc-6S sulphatase requires the 
sequential action of two enzymes: desulphation by GlcNAc-6S sulphatase followed 
by hydrolysis by ~-N-acetylglucosaminidase. To avoid the second step becoming 
rate limiting, a second incubation (6h) in the presence of extra added a-N- 
acetylglucosaminidase (22 nmol/6 h; specific activity: 234 nmol/h per mg protein) was 
carried out routinely. This was the minimum amount of ~-N-acetylglucosaminidase 
that could in 6 h quantitatively hydrolyse any amount of MU-~GlcNAc between 10 
and 2000pmol. This exogenous enzyme source, a glycoprotein fraction of bovine 
origin, also contained GlcNAc-6S sulphatase activity (11 nmol/6h), however, this 
activity did not interfere since it could be inhibited completely by the high 
concentration of phosphate used in the standard assay (substrate blanks, also 
incubated with exogenous enzyme were only 30-40 pmol). Omission of the second 
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Figure ! Effect of lead acetate on GIcNAc-6S sulphatase activity in normal leukocyte 
(squares) and fibroblast homogenates (triangles). Open symbols, with lead acetate (10 mmol/L); 
solid symbols, without lead acetate. Reaction conditions as in standard assay except for 
amount of protein. Solid circles, dialysed fibroblast homogenate without lead acetate 
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step resulted in underestimation f GlcNAc-6S sulphatase in leukocytes by 98% and 
in fibroblast by 70-80%. 
In the experiments shown below, the GlcNAc-6S sulphatase was assayed under 
standard conditions as described in Materials and Methods (except for the condition 
that was varied). The pH optimum of the GlcNAc-6S sulphatase from leukocytes and 
fibroblasts was pH 5.8 (Figure 2). We chose pH 5.6 for the standard assay because 
acetate buffer has insufficient buffering capacity above this pH. The apparent K m was 
estimated to be 9 mmol/L for leukocytes and 6 mmol/L for fibroblasts (Figure 3). The 
sulphatase activity was approximately inear with time up to 24 h (Figure 4). 
Under standard assay conditions the GlcNAc-6S sulphatase activities were deter- 
mined in material from patients and controls. The three investigated patients, 
originating from the Netherlands and France, had no detectable GlcNAc-6S sulphat- 
ase activity in leukocytes or fibroblasts (Table 1). Fibroblasts from a patient with 
multiple sulphatase deficiency had 3% activity, whereas patients with Sanfilippo 
disease types A, B and C had normal GlcNAc-6S sulphatase activity (Table 1). 
DISCUSSION 
We have defined conditions for the assay of GlcNAc-6S sulphatase using the 
fluorogenic substrate 5-methylumbelliferyl-~-D-N-acetylglucosamine 6-sulphate 
(MU-eGlcNAc-6S). Formation of the fluorochrome requires the sequential ction of 
both GlcNAc-6S sulphatase and c~-N-acetylglucosaminidase. Underestimation f the 
sulphatase activity could be avoided by subjecting the reaction mixtures to a second 
incubation with excess e-N-acetylglucosaminidase under condition where exogenous 
GlcNAc-6S sulphatase activity was inhibited completely by a high concentration of
phosphate. 
MU-c~GlcNAc-6S was shown to be useful in the diagnosis of Sanfilippo type D 
disease. The residual activities in cells from the three MPS IIID patients we 
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Figure 2 pH dependence of GlcNAc-6S sulphatase activity in normal leukocytes (E]; right 
scale) and fibroblasts (A; left scale). Reaction conditions as in standard assay, except for pH 
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Figure 3 Lineweaver-Burk plot for GlcNAc-6S sulphatase activity in normal eukocytes (a) 
and fibroblasts (b). Reaction conditions as in standard assay, except for MU-~GIcNAc-6S 
concentration 
investigated were < 1% of the mean control activity, and the sulphatase activity in 
cells from a patient with multiple sulphatase deficiency was 3%. The conventional 
GlcNAc-6S sulphatase assay uses radiolabelled oligosaccharides, derived from hepa- 
ran sulphate (Kresse et al 1980; Freeman and Hopwood 1992); this is still the most 
widely used assay. Nawakowski et al (1989) have described a GlcNAc-6S sulphatase 
assay with the monosaccharide GlcNAc-6S. This method requires separation of 
substrate and free GlcNAc and is based on the colorimetric determination fGlcNAc. 
Our fluorogenic assay is sensitive and specific and obviously more convenient than 
the existing assays. 
In undialysed homogenates, the GlcNAc-6S sulphatase activity was barely detect- 
able. This suggested the presence of inhibitors, possibly inorganic sulphates and 
phosphates, which are known powerful inhibitors of GlcNAc-6S sulphatase (Basher 
et al 1979). It was surprising that the activity in dialysed homogenates was still 
extremely low and reached a plateau with only 3-5#g protein, suggesting that 
inhibitors were still present in the reaction mixtures. Addition of lead acetate to the 
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Figure 4 Time course of GlcNAc-6S sulphatase activity in normal leukocytes (N) and 
fibroblasts (A). Reaction conditions as in standard assay, except for incubation time 
Table 1 GlcNAc-6S sulphatase activity in ieukocytes and fibroblasts 
GIcNAc-6S sulphatase activity 
Leukocytes 
(nmol/24 h per rag) 
Fibroblasts 
(nmol/17 h per mg) 
Normal range 14-22 (n = 11) 41-86 (n = 12) 
(mean + SD) (18 + 3) (57 _+ 14) 
Sanfilippo D patient(s) 0.0 (n = 1) 0.0 (n = 3) 
Multiple sulphatase deficiency 1.8 
Sanfilippo A (n = 1) 60 
Sanfilippo B (n = 1) 42 
Sanfilippo C (n = 1) 52 
reaction mixtures, which will precipitate traces of free sulphates and phosphates, 
increased the activities > 10-fold and also resulted in a nearly linear relationship 
between enzyme activity and amount of protein. We concluded that inorganic 
phosphates and sulphates are formed during the incubation and that these trace 
amounts must be removed. 
Assays with MU-substrates requiring more than one enzyme to yield the fluoro- 
chrome are uncommon. This principle was successfully applied for the first time for 
galactose-6-sulphate sulphatase to allow the diagnosis of Morquio disease type A (van 
Diggelen et al 1990) and recently for acetyl-CoA : glucosaminide-N-acetyltransferase, 
which facilitated the diagnosis of Sanfilippo disease type C (Voznyi et al 1993). This 
approach could also result in replacement ofother cumbersome radiochemical ssays. 
Potential MU substrates for the diagnosis of MPS IIIA and MPS II are currently 
being synthesized. 
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